WUXI BIOLOGICS (CAYMAN) INC.

Analyst Reco. WuXi Biologics (Cayman) Inc.

Equities

2269

KYG970081173

Delayed Hong Kong S.E. Other stock markets 23:41:51 2024-04-28 EDT			5-day change	1st Jan Change
14.28 ^HKD	+5.93%		+11.72%	-51.69%

04-01	Wuxi Biologics Inc. Announces Retirement of Weichang Zhou as Chief Technology Officer and President of Global Biologics Development and Operations and Re-Designates as Non-Executive Director and Honorary President of Global Biologics Development and Operations and Senior Advisor to Chief Executive Officer	CI
03-27	WuXi Biologics' 2023 Profit Falls 23% Despite Revenue Jump	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nomura Adjusts Wuxi Biologics' Price Target to HK$53.65 From HK$58.44, Keeps at Buy	03-01	MT
Hong Kong Stocks Rebound Over Unchanged Fed Rates; Wuxi Up 3%	02-01	MT
Nomura Adjusts Wuxi Biologics’ Price Target to HK$58.44 From HK$82.69, Keeps at Buy	12-05	MT
Nomura Adjusts Wuxi Biologics' Price Target to HK$82.69 From HK$86.68, Keeps at Buy	23-07-24	MT
Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$86.86 From HK$94.91, Keeps at Buy	23-06-21	MT
Nomura Adjusts WuXi Biologics' Price Target to HK$94.91 From HK$97.78, Keeps at Buy	23-02-14	MT
New energy shares drag China stocks lower, Fed rate-decision jitters weigh	22-09-15	RE
UBS Adjusts Wuxi Biologics’ Price Target to HK$113.12 From HK$110.67, Keeps at Buy	22-08-22	MT
Nomura Adjusts WuXi Biologics' Price Target to HK$97.78 From HK$95.75, Keeps at Buy	22-08-05	MT
UBS Adjusts Wuxi Biologics (Cayman)'s Price Target to HK$95.75 From HK$100.87, Keeps at Buy	22-06-08	MT
China stocks rise on higher-than-expected borrowing rate cut; foreign inflows surge	22-05-20	RE
UBS Adjusts Wuxi Biologics' Price Target to HK$110.67 From HK$142, Keeps at Buy	22-03-29	MT
Nomura Adjusts WuXi Biologics' Price Target to HK$100.87 From HK$103.28, Keeps at Buy	22-03-24	MT
Nomura Adjusts WuXi Biologics' Price Target to HK$103.28 From HK$149.92, Keeps at Buy	22-03-17	MT
China stocks fall as virus worries, Fed rate hike bets weigh; Hong Kong up	22-01-11	RE
WUXI BIOLOGICS CAYMAN : Nomura Adjusts WuXi Biologics' Price Target to HK$116.8 From HK$213.1, Keeps at Buy	21-03-29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer